173251-53-1

Basic information

• Product Name: Benzoic acid, 5-formyl-2-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester
• CAS NO: 173251-53-1
• Molecular Formula: C10H7F3O6S
• Molecular Weight: 312.223
• Mol File: 173251-53-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 5-formyl-2-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 5-formyl-2-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester(173251-53-1)
• EPA Substance Registry System: Benzoic acid, 5-formyl-2-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester(173251-53-1)

Safety Data

• Hazardous Substances Data: 173251-53-1(Hazardous Substances Data)

Upstream product

• 358-23-6 trifluoromethylsulfonic anhydride 
• 41489-76-3 methyl-5-formyl-2-hydroxybenzoate 
• 616-76-2 2-hydroxy-5-formylbenzoic acid 

Downstream Products

• 239463-09-3 3-methoxycarbonyl-4-trifluoromethylsulfonyloxybenzoic acid 
• 301684-02-6 methyl 5-(isobutylamino)carbonyl-2-{[(trifluoromethyl)sulfonyl]oxy}benzoate 
• 790230-03-4 2'-[4-(tert-butoxycarbonylamino-methyl)-phenylcarbamoyl]-4-isobutylcarbamoyl-biphenyl-2-carboxylic acid methyl ester 
• 790230-32-9 2'-(3-carbamoyl-phenylcarbamoyl)-4-isobutylcarbamoyl-biphenyl-2-carboxylic acid methyl ester 

Relevant articles and documents

BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.

Synthetic strategies to derivatizable triphenylamines displaying high two-photon absorption

(Chemical Equation Presented) A versatile synthetic strategy to access a set of highly fluorescent π-conjugated triphenylamines bearing a functional linker at various positions on one phenyl ring is described. These compounds were designed for large two-photon absorption (2PA) and in particular for labeling of biomolecules. The monoderivatized trisformylated or trisiodinated intermediates described herein allow introduction of a large variety of electron-withdrawing groups required for large 2PA as well as a panel of chemical functions suitable for coupling to biomolecules. The monoderivatized three-branched compounds and in particular the benzothiazole (TP-3Bz) series show remarkable linear (high extinction coefficients and high quantum yield) and nonlinear (high 2-photon cross sections) optical properties. Interestingly the presence of functional side chains does not disturb the two-photon absorption. Finally, monoderivatized two-branched derivatives also appear to be valuable candidates. Altogether the good optical properties of the new derivatizable π-conjugated TPA combined with their small size and their compatibility with bioconjugation protocols suggest that they represent a new chemical class of labels potentially applicable for the tracking of biomolecules using two-photon scanning microscopy.

Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3

Fused tricyclic compounds, methods of using such compounds in the treatment of hormone sensitive diseases such as prostate cancer, and pharmaceutical compositions containing such compounds.